WallStreetZenWallStreetZen

NASDAQ: LSTA
Lisata Therapeutics Inc Stock Ownership - Who owns Lisata Therapeutics?

Insider buying vs selling

Have Lisata Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David J. MazzoChief Executive Officer2024-01-111,026$2.99
$3.07kSell
Kristen K. BuckEVP RD and CMO2024-01-10512$3.00
$1.54kSell
David J. MazzoChief Executive Officer2024-01-103,470$3.00
$10.41kSell
David J. MazzoChief Executive Officer2024-01-0912,203$3.08
$37.59kSell
David J. MazzoChief Executive Officer2024-01-097,843$3.08
$24.16kSell
Kristen K. BuckEVP RD and CMO2024-01-092,147$3.08
$6.61kSell
Kristen K. BuckEVP RD and CMO2024-01-093,221$3.08
$9.92kSell
Kristen K. BuckEVP RD and CMO2023-09-012,908$2.18
$6.34kSell

1 of 1

LSTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LSTA insiders and whales buy or sell their stock.

LSTA Shareholders

What type of owners hold Lisata Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Rimasia Capital Partners Manager Ltd296.52%24,632,862$69.71MInsider
Jr Family Trust Aholt148.69%12,352,227$34.96MInsider
Robert Joseph Aholt Jr.140.26%11,652,230$32.98MInsider
Caribbean Stem Cell Group Inc75.23%6,250,000$17.69MInsider
Eric Wei54.78%4,550,499$12.88MInsider
Enhance Biomedical Holdings Ltd48.15%4,000,000$11.32MInsider
Mingsheng Shi46.05%3,825,770$10.83MInsider
Jian M. Zhang46.05%3,825,770$10.83MInsider
Fullbright Finance Ltd36.68%3,047,432$8.62MInsider
Wayne A. Marasco32.34%2,686,713$7.60MInsider

1 of 3

LSTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LSTA0.84%99.16%Net Selling
CNTX22.29%7.22%
LUMO17.70%82.30%Net BuyingNet Buying
SYBX3.98%96.02%Net SellingNet Selling
SER12.90%87.10%

Lisata Therapeutics Stock Ownership FAQ

Who owns Lisata Therapeutics?

Lisata Therapeutics (NASDAQ: LSTA) is owned by 8.93% institutional shareholders, 1,050.04% Lisata Therapeutics insiders, and 0.00% retail investors. Rimasia Capital Partners Manager Ltd is the largest individual Lisata Therapeutics shareholder, owning 24.63M shares representing 296.52% of the company. Rimasia Capital Partners Manager Ltd's Lisata Therapeutics shares are currently valued at $65.52M.

If you're new to stock investing, here's how to buy Lisata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.